Bedford Laboratories has voluntarily recalled a single lot of its ‘Vecuronium Bromide for injection’ product due to “particulate matter,” according to an FDA news release.
Read the full report in Becker’s ASC Review on the voluntary recall.
Adjunct Product for General Anesthesia Recalled
Why efficiency is becoming the new growth strategy for ambulatory care organizations
Recommended Whitepaper